---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041801"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2026-09-08T21:24:25+00:00"
generated_at: "2026-09-08T21:26:08.781712+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharmaceuticals issues $500K secured convertible note to Gravitas Capital

## Summary
- $500,000 secured convertible note with 8% paid-in-kind interest, maturing Sept 3, 2027.
- Note convertible at $0.04/share, contingent on stockholder approval to increase authorized shares.
- Warrant to buy 12.5M common shares at $0.06, exercisable until Sept 3, 2031.
- Note secured by all company assets; sale is unregistered under Regulation D/4(a)(2).

## SEC filing metadata
- accession: 0001493152-26-041801
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2026-09-08T21:24:25+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/0001493152-26-041801-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041801
- JSON: https://secwatch.observer/filing/0001493152-26-041801.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041801.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.